Dear colleagues, dear friends,
With great respect and pleasure, we invite you to attend the International Ophthalmology Symposium – “Glaucoma as comorbidity, comorbidities in glaucoma”, which will be the main event in the frame of the Week of Glaucoma, organized by the Macedonian Ophthalmology Association.
The symposium will be held on 16.03.2024 and will take place at Hotel Double Tree by Hilton.
Glaucoma represents one of the most common ophthalmologic diseases, with lifelong treatment, starting with diagnosis established.
The chronic character and high incidence of this disease imply the need for a broader understanding of this complex condition. By “ broader understanding “, we think the first place of the interaction of glaucoma with the other coexisting ophthalmologic and systemic diseases in these patients. This interaction has a great impact on all sectors, from detection, treatment modalities, and the course of the disease, but vice versa, glaucoma also impacts the treatments of the coexisting diseases, to the level of choices of surgical procedures. Hence the topic of this symposium is glaucoma as comorbidity, commorbidities in glaucoma.
We think that the lectures and presentations on this topic, which will be held by leading experts in glaucoma from abroad and in Macedonia, will be of significant interest and benefit to the ophthalmologists in Macedonia and will result in improvements in all aspects of glaucoma – detection, treatment, follow up.
The lectures presented at this symposium will be published both on our site and in printed form, and distributed to the ophthalmologist members of the Macedonian ophthalmologist society and attendees. The other derivate of this symposium, not less important, will be a published and printed guideline brochure for non-ophthalmologists, primarily general practitioners, family doctors, internal medicine specialists, opticians, and optometrists, all of which can significantly contribute through their daily practice in earlier detection of glaucoma, consequently in improved and more efficient treatment of this common, chronic and insidious disease.
This symposium is accredited by the Doctors Chamber of Macedonia.
We cordially invite you to attend and support this event in the best interest of all participants – practitioners, industry, and above all, in the best interest of the patients.
Dr. Dejan Stavric
Macedonian ophthalmologic Society